Header cover image

Polish (WIG) Biotech Industry Analysis

UpdatedJul 17, 2024
DataAggregated Company Financials
Companies12
  • 7D-0.7%
  • 3M-3.4%
  • 1Y-17.3%
  • YTDn/a

Over the last 7 days, the Biotech industry has risen 1.7%, driven by gains in Captor Therapeutics Spolka Akcyjna and Synthaverse of 4.8% and 3.8%, respectively. During this same period, the Read-Gene underperformed, falling 8.4%. In contrast, the industry has lost 17% in the last 12 months.

Industry Valuation and Performance

Has the Polish Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 17 Jul 2024zł2.1bzł444.2m-zł64,230,755.0071x-32.9x4.8x
Fri, 14 Jun 2024zł2.0bzł439.7m-zł90,277,755.0071x-22.3x4.6x
Sun, 12 May 2024zł2.3bzł441.3m-zł90,006,665.0056.2x-25.2x5.1x
Tue, 09 Apr 2024zł2.2bzł432.0m-zł73,964,007.0061.5x-29.7x5.1x
Thu, 07 Mar 2024zł2.3bzł462.1m-zł74,341,007.0056.2x-30.9x5x
Sat, 03 Feb 2024zł2.7bzł499.9m-zł66,755,911.0085x-40.5x5.4x
Mon, 01 Jan 2024zł2.7bzł499.9m-zł66,755,911.0087x-40.6x5.4x
Wed, 29 Nov 2023zł2.6bzł498.2m-zł58,578,911.0096.8x-44.5x5.2x
Fri, 27 Oct 2023zł2.7bzł518.4m-zł60,859,678.0046.2x-44.1x5.2x
Sun, 24 Sep 2023zł2.8bzł518.5m-zł61,744,678.0050.4x-44.9x5.4x
Tue, 22 Aug 2023zł2.8bzł520.3m-zł43,292,668.0051.6x-64.5x5.4x
Thu, 20 Jul 2023zł2.9bzł520.7m-zł42,515,291.0053.9x-68.7x5.6x
Sat, 17 Jun 2023zł2.8bzł517.3m-zł42,548,721.0062.6x-66.8x5.5x
Mon, 15 May 2023zł2.9bzł520.8m-zł42,603,826.0065.9x-69.2x5.7x
Wed, 12 Apr 2023zł2.8bzł492.8m-zł18,098,449.0060.7x-156.2x5.7x
Fri, 10 Mar 2023zł2.9bzł488.6m-zł16,165,349.0065.2x-178.3x5.9x
Sun, 05 Feb 2023zł3.0bzł496.5m-zł10,783,764.0047.4x-274.3x6x
Tue, 03 Jan 2023zł2.8bzł496.5m-zł10,783,764.0047x-256.8x5.6x
Thu, 01 Dec 2022zł2.8bzł457.9m-zł19,209,766.0048.5x-145.4x6.1x
Sat, 29 Oct 2022zł2.7bzł444.0m-zł13,473,868.0058.2x-197.2x6x
Mon, 26 Sep 2022zł2.6bzł401.7m-zł21,088,868.0059x-122.4x6.4x
Wed, 24 Aug 2022zł2.7bzł390.2m-zł7,043,258.0061.5x-380.4x6.9x
Fri, 22 Jul 2022zł2.5bzł472.9mzł66,686.0027.5x38116.8x5.4x
Sun, 19 Jun 2022zł2.3bzł472.3mzł5.7m24.9x408.1x4.9x
Tue, 17 May 2022zł2.6bzł424.4mzł11.6m42.2x225.7x6.2x
Thu, 14 Apr 2022zł2.7bzł366.7m-zł37,207,677.0032.3x-71.5x7.3x
Sat, 12 Mar 2022zł2.7bzł348.8m-zł40,884,677.0028.4x-65.3x7.7x
Mon, 07 Feb 2022zł3.3bzł369.9m-zł24,922,742.0049.2x-131.5x8.9x
Wed, 05 Jan 2022zł3.7bzł369.9m-zł24,922,742.0049.2x-146.6x9.9x
Fri, 03 Dec 2021zł3.8bzł369.9m-zł24,922,742.0049.2x-151.4x10.2x
Sun, 31 Oct 2021zł3.7bzł364.5m-zł1,455,285.0032.9x-2519.2x10.1x
Tue, 28 Sep 2021zł3.7bzł364.5m-zł1,455,285.0037.1x-2573.6x10.3x
Thu, 26 Aug 2021zł3.6bzł362.9m-zł8,912,285.0040x-406.3x10x
Price to Earnings Ratio

-412x


Total Market Cap: zł3.7bTotal Earnings: -zł8,912,285.00Total Revenue: zł362.9mTotal Market Cap vs Earnings and Revenue0%0%0%
Polish Biotech Industry Price to Earnings3Y Average 1540.7x202220232024
Current Industry PE
  • Investors are pessimistic on the Polish Biotechnology industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 6.5x is higher than the industry's current PS ratio of 4.8x.
Past Earnings Growth
  • The earnings for companies in the Biotechnology industry have deteriorated over the last three years.
  • Meanwhile revenues for these companies have grown 7.0% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.

Industry Comparison

How does Polish Biotech compare with similar industries?

PL Market-2.49%
Healthcare-3.93%
Biotech-0.69%
Biotech-0.69%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
PUR Pure Biologicszł12.8033.3%
+zł10.6m
-25.8%PS617.3x
URT Urtestezł88.000.2%
+zł281.9k
-20.0%PS126.5x
GMT Genomteczł10.680.2%
+zł266.5k
19.5%PB25.2x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

MAB

zł17.24

Mabion

7D

-1.3%

1Y

-4.0%

BCX

zł63.80

Bioceltix

7D

-0.2%

1Y

-14.9%

PTG

zł49.10

Poltreg

7D

-2.2%

1Y

-13.9%

GX1

zł6.08

genXone

7D

-0.3%

1Y

-30.1%

PUR

zł12.80

Pure Biologics

7D

33.3%

1Y

-25.8%

SCS

zł0.36

Stem Cells Spin

7D

-3.7%

1Y

1.1%

GMT

zł10.68

Genomtec

7D

0.2%

1Y

19.5%

URT

zł88.00

Urteste

7D

0.2%

1Y

-20.0%